Darae Ko is a Cardiology physician affiliated with Boston University. OpenAlex indexes 127 publications with 14,026 citations (h-index 28). By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
732 Harrison Ave
Fl 3 Preston Bldg
Boston, MA 021182309
Telephone
617-638-7490Provider last certified this registry record 13 Apr 2026.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Pharmaceuticals, Inc.Program year20257 payments
- Regeneron Pharmaceuticals, Inc.Program year20243 payments
- Eagle Pharmaceuticals, Inc.Program year20224 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
87.1%Statin18.7%Atorvastatin Calcium81%Rosuvastatin Calcium19%Part D<11 patientsBeta blocker18.7%Metoprolol Succinate100%Part D≥28 patients+ 10 more classes in this area
Blood & clotting
12.9%Factor Xa inhibitor12.9%Eliquis86%Xarelto14%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:
- Utilization and Clinical Outcomes of Left Atrial Appendage Occlusion in Older Adults with Atrial Fibrillation and Frailty
Hebrew Rehabilitation Center for Aged
FY2026$699,392R01HL175560 - Improving Informed Decision Making Through Real-World Safety Monitoring of New Alzheimer's Treatments
Hebrew Rehabilitation Center for Aged
FY2026$671,336R01AG094761 - GUIDE AF: Guiding Anticoagulation Decisions for Atrial Fibrillation in Long-Term Care
Hebrew Rehabilitation Center for Aged
FY2026$670,774R01AG100018
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
David Felson, MD
Boston University
Gene Kwan, MD
Boston University
Gary Balady, MD
Boston University
Andrew Budson, MD
Boston University
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”